Approval · Notice of Compliance 37053 · 2026
RADICAVA: Notice of Compliance 37053
Issued March 6, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37053
- Date
- March 6, 2026
- Company
- Tanabe Pharma Corporation
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in manufacturer name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RADICAVA | 02532611 | Marketed |
Medicinal ingredients
- EDARAVONE 105 MG per 5ML